ouabain has been researched along with eplerenone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gabor, A; Leenen, FH | 1 |
Breitenbach, S; Jurkat-Rott, K; Lehmann-Horn, F | 1 |
2 other study(ies) available for ouabain and eplerenone
Article | Year |
---|---|
Mechanisms in the PVN mediating local and central sodium-induced hypertension in Wistar rats.
Topics: Aldosterone; Amiloride; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Cerebrospinal Fluid; Diuretics; Dose-Response Relationship, Drug; Eplerenone; Heart Rate; Hypertension; Injections, Intraventricular; Losartan; Ouabain; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Sodium; Spironolactone | 2009 |
Eplerenone repolarizes muscle membrane through Na,K-ATPase activation by Tyr10 dephosphorylation.
Topics: Animals; Cell Line; Diaphragm; Enzyme Inhibitors; Eplerenone; Membrane Potentials; Mice; Mineralocorticoid Receptor Antagonists; Muscular Dystrophy, Duchenne; Ouabain; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; RNA, Messenger; Sodium-Potassium-Exchanging ATPase; Spironolactone; Transcription, Genetic | 2016 |